What if things go right with the carcinoma treatment? How long we expect to live affects how we live

Since finding out that the petosemtamab / MCLA-158 clinical trial drug I’m receiving has been shrinking my tumors, I’ve been considering a question that, as of July 21, I’d banished from my mind: What if things go right? Plus: What if I unexpectedly survive for an extended period of time? “Extended” as in, conceivably years (plural). Although it’s improbable that I’ll get what’s called in the clinical-trial business “complete response,” or total elimination, published phase 1 trial data shows that petosemtamab is effective for about six months for the median person suffering head and neck cancer.

After petosemtamab stops being effective, however, I’ll be able to switch to another clinical trial drug, with a different mechanism of action, and, as I wrote in “Tentative, fluttering optimism: The R & D ferment in head and neck cancer treatment,” there are at least three and probably more than half a dozen treatments that’ve shown some success. In July, I didn’t realize that there were any apart from Keytruda, which I’d already failed, and my primary oncologist then either didn’t know anything about the clinical-trial successes in his field (which is bad) or didn’t tell me about them (which might be worse).

In July, I assumed that I’d live weeks to months, and that short lifespan projection wasn’t unreasonable: the squamous cell carcinoma that started in my tongue has been relentlessly fast and aggressive. Extensive radiation therapy barely slowed it, and throughout May the tumor recurred so rapidly and grew so unexpectedly that, instead of losing half my tongue (as was anticipated), I lost all of it. The May 25 salvage surgery, combined with Keytruda, could have been curative, but, well, we know how that turned out: the cancer was back and bigger than ever in under two months. There were four tumors in my neck and multiple “nodules” presumed to be cancer in my lungs. Pessimism was warranted: Chemo is only palliative for what I have, and Keytruda only works for 20 – 30% of patients, me not among them.

Bess responded to the ill news by spending almost every waking hour for six weeks after my metastatic recurrence learning about the clinical trial system; the result is her epic tale and guide, “Please be dying, but not too quickly: A three-part, very deep dive into the insanity that is the ‘modern’ clinical trial system.” She turned out to be more helpful, and infinitely more interested, than some of the head and neck oncologists we talked to, some of whom had never heard of petosemtamab or BCA-101, two of the most promising HNSCC treatments. While Bess mastered the clinical trial system, I got two rounds of chemotherapy, which, on top of a continuing recovery from the brutal surgery, made me feel barely alive. Despite making me feel abysmal, those chemo rounds bought some time and, thanks to Bess’s efforts, I enrolled in the petosemtamab trial at UCSD.

Moreover, as mentioned above, CT scans after two months of petosemtamab treatment show that it’s effective: the tumors in my neck and lungs are now, on average, about 12.5% smaller than they were on Sept. 5. I’m still far from doing great, but I’m a little better than I was through the most intense parts of the surgery recovery, then the chemo, and then an indolent infection in a necrotic lymph node on the right side of my neck. I’m better able to take care of myself and Bess is planning to go back to work. The cancer is almost certainly still going to kill me, but we have a legitimate plan for keeping it at bay for as long as possible. How long? I don’t know. Not knowing makes it tough to figure out what to do with the life I have left. When I thought I was going to be gone in weeks to months, I focused on saying goodbye.*

Now what? Focus on saying hello, which is I guess the antonym of saying goodbye? How much should I focus on working for money? If I’m only going to live for six months, the answer is “Not much.” “Six years” yields a different priority and behavior set. The questions are unanswerable, though I have to answer them through my choices, despite them not being deterministic or computable. In the last five months, mere survival has been the desperate goal, and in pursuing that goal I’ve been thankful for and blessed in the generosity of friends, readers, and strangers in contributing to the Go Fund Me that my brother set up, which has let Bess and me focus on physical and medical challenges more than financial ones. I’ve been terribly sick, and lucky for the support, particularly in light of the mystery five-figure bills that are peculiarly not covered by United Healthcare (a topic to be further explored in the future). Because of the Go Fund Me, I’ve not been forced into the brutal, impossible decisions many cancer patients face, and for that I’m grateful. Even so, getting and staying sick for long periods of time is hard; I’m highly pro-vaccine for lots of reasons, the main one being that being sick sucks and being healthy is better. Granted, being sick is better than dying, most of the time.

In some sense everyone’s future is unknowable; lots of friends correctly point out that anyone can die at any time. While that’s obviously true, most of us expect, most of the time, to live into, say, our 70s—and actuarial tables agree. Call it 75 meaningful years. Some people get more, but by 75 a person has to wonder, at current levels of medical technology, how much is left and what the quality of what’s left might be. People in their 30s, unless they have a terminal disease, anticipate and act with decades in mind; most of us are raising families or trying to have kids, building assets, and developing careers. Memento mori, yes, yes, and the knowledge that life is fleeting, should drive us to do things that are meaningful and eschew common bullshit like bad TV or short-form video or petty feuds—all the stuff that life’s too short for. Overall, though, we plan to live more than we plan to die.

Ryan Holiday observed in an email:

[Y]ou are the inverse of what most of us wrestle with day to day. There is a small probability that we could die soon, but we probably won’t. So we have to plan for the future practically and figure out how to live accordingly. Yours is the opposite. You are staring at the likelihood of death but you could live. You have to prepare and plan accordingly, make sense of that philosophically. It must be very strange…though I guess when I think about it like this, it’s pretty strange for all of us.

If things go right, things will also have to change. I won’t be able to pitch clients the way I did back when I had a tongue, for example—I’m hard to understand on the phone. I’m less energetic, and I have hours each day of food and medical care that can’t be ignored. Bess and I have been trying to have a kid; what’s that look like? When I saw the dreaded news in July—”likely multifocal disease recurrence along the flap margins and posterior sternocleidomastoid” and “there are multiple new enhancing masses concerning for multiple areas of disease recurrence predominantly along the inferior margin of the flap, with an additional 1.9 cm necrotic mass between the right internal jugular vein and sternocleidomastoid muscle”—Bess was talking on her phone to a realtor about buying a housing unit.

Everyone faces known unknowns and unknown unknowns, but we plan and execute our lives as best we can, knowing that we’ll likely get our future selves wrong (a topic Bess addresses in “Remembering things that haven’t happened yet: How will I know what I need to hear in a future I can’t anticipate? Who will I be, and what will she want?”). I have a larger number of unknowns, though, relative to the average person my age. I’ve adjusted my life in other ways, too; I’ve not been seeking out new friendships in everyday life to the extent I used to. Part of that is because being hard to understand makes cultivating casual friendships hard. And, if I’m going to die in a couple months, I want to focus exclusively on the people I know and on saying goodbye. If not, then I don’t want to lead a life of loneliness, as so many people do now, often, I think, inadvertently. There’s never a deliberate decision to pursue isolation, just a series of smaller choices that wind up with radical disconnection and the unhappiness that brings. Drift and complacency rule so much of human life, yet no one gets to the end and says, “I wish I’d drifted more. I wish I’d been more complacent.” Hardly anyone regrets energetically pursuing goals, ideas, knowledge, or business, but drift, inertia, complacency—they’re bad. We may not get our future selves right, but we can try to reduce the regrets of our future self.

If things go right, much will change, not only with making new friends and associates, but with maintaining old ones. It’s been hard to keep up, verbally, with friends. Most days I don’t have the energy to go out and do normal things with people. Friendships become attenuated over time as the casual touches—phone calls, coffees, adventures, whatever—slide away. So much of my old life feels like it’s sloughing off. I’ve met new friends through writing online, and some old friends have resurfaced, so the writing has produced some benefits I didn’t anticipate.

Many previous hobbies and interests probably won’t work anymore. Maybe some of my previous hobbies and interests were rooted in young adulthood, and the true adult interests of mature adulthood are coming in but aren’t quite there yet (a lot of people who live in New York can’t or think they can’t afford kids, giving them a Peter Pan quality). Probably I will never do MDMA again, despite its virtues for relationships. Other psychedelics are possible. Probably I will ride electric bikes again. Teaching? Probably not. I miss teaching, but doing it the conventional, legacy way through existing colleges and universities has so little money in it that, despite liking to teach, I’ve been waffling for years about whether it’s worthwhile. And now I’d have to struggle to be understood.

A lot of spontaneous go-places-and-do-things adventures are out: I’m too fragile and too encumbered by the gear necessary to support life. Not everyone agrees. When I said to Bess that something like, say, a week in Italy seems impossible, she surprised me by quickly rattling off a plan to rent a room above a bookshop somewhere in Tuscany and manage PEG tube feedings (I’m supposed to get a “button” PEG tube installed soon, which will sit flush against my stomach and be less of a hassle)—plus, what kind of European conversion plug the VitaMix would require and how to fit in a weekend in Rome, as if she’d been planning a potential trip for the last month, which, who knows, maybe she has. She’s a surprising, energetic woman. A week in Italy still sounds like excessive struggle, but her detailed thoughts demonstrated that having a wife who likes to travel and troubleshoot is useful for more than clinical trials. She’s really telling me, I think, that if I somehow survive this, however improbable survival is, if my life is somehow one day not utterly dominated by treatment needs, we’re not merely going to survive; we’re going to thrive.

The old ways are dead, but have the new ones been born? I’m not sure, but I’m trying to find out.

If you’ve gotten this far, consider the Go Fund Me that’s funding ongoing care.


* For me, although petosemtamab is extremely unlikely to be curative, after it perhaps there will be nt219, which, in a phase 1 study, found that two of four head and neck squamous cell carcinoma (HNSCC) patients saw “partial response.” And after that something else, like Seagen’s SGN-PDL1V (Pfizer just bought Seagen for $43 billion, implying a lot of belief in Seagen’s drug pipeline). Or maybe petosemtamab will turn me into a Keytruda responder.

Finally, some good tumor news, but, also, hacking up blood is probably bad

On Wednesday at Mayo I got unscheduled CT scans, and they show that the squamous cell carcinoma tumors in both my neck and lungs are (mostly) smaller, relative to August 13. There are some new tumors in the lungs,* which is obviously not ideal, but the shrinkage of most tumors is really good. Two tumors in my neck appear somewhat larger, but that could be secondary to the biopsies performed on those tumors as part of the UCSD petosemtamab clinical trial, since biopsies can cause an inflammatory response that can’t be distinguished from new tumor burden via CT.

One other significant piece of evidence supports the theory: that I remain headache-free is a mark in the “this is likely inflammation” column. Regular readers may recall that I didn’t have any treatment for most of September, due to the six-week washout period 🤮 required for the petosemtamab trial, and by the end of that washout period I was getting ominous headaches that later resolved without intervention, apart from the petosemtamab. 

Bess sent a CD containing the CT scan data files to UCSD, because I assume Dr. Sacco, my oncologist there, will want the UCSD radiologists to look at them too.** It’s conceivable that the UCSD radiologists will have a materially different read than the Mayo ones, but I’d guess differences will be small. Considering how many of my guesses about the cancer have been wrong, I should probably quit guessing, but I’m still doing it. If my cancer were a prediction market using real money, I’d be broke by now from getting so much wrong.

“But Jake,” you might ask after reading the preceding paragraphs, “you said previously that your CT scans are scheduled for today? What gives?” 

I’m glad you ask, or might ask, or accept me putting words in your mouth for purposes rhetorical: on Wednesday morning I woke up and, per the usual, trundled half-asleep to the kitchen. As I’ve done hundreds of times since the May surgery that took my tongue, I drank some water and expelled the mucus plugs in my throat. I grabbed the faucet to wash away the results, but said results woke me right up because I saw something bizarre: the mucus plugs were…red. Red? Why red? Is that blood? Sure looks like blood. Looks like blood came out of my throat. There more where that came from? What’s the cause? 

I called to my personal physician: “Can you come look at something?” Much later, Bess said that “Can you come look at something?” has become her least-favorite query, especially if it’s coming from the bathroom or, now, the kitchen, because it usually means something confusing or bad (or both) is on my body, in my body, or coming out of my body. In the moment, Bess examined the bottom of the sink and said, authoritatively, indeed with all the authority that comes from medical school and a decade and a half in medicine: “That looks like blood.” I concurred, though without her authority. If you’re the sort of person who wants to see for yourself, scroll to the very bottom of this essay for the pictures. They’re deliberately way down there so that people who don’t want to see them are less likely to.

She dropped immediately into doctor mode and started quizzing me, to the point that I felt like I was a multiple-choice medical exam. I told her: no pain, no trouble breathing, no idea apart from the obvious where it’s coming from. She used a phone light to look in my mouth. Nothing. For the first time in a while, she didn’t poke anything with or without warning me first. Possibly, because she was afraid of irritating whatever was the source of this morning’s exciting new symptom. I spit some more, hacking much more gently this time, and we didn’t see much that was bloody, but we didn’t have a cause. I tasted a little blood in the back of my throat. I’ve probably not become a vampire with an insatiable desire for humans, unless the vampire part of my nature also includes amnesia (Bess’s reports of fang marks on her upper arm are patently false: fake news, nothing to see here). 

What to do? We planned to go to the ER, because active bleeding in the throat is not good. I’ve not been to medical school except through proximity, but “active bleeding in the throat is not good” was my expert medical opinion. As we got ready, Bess thought to call the Mayo ear, nose, and throat (ENT) department, because the likely outcome of the ER visit would be an ENT consult, in which an ENT resident comes down to the ER and does a “scope.” A “scope” means spraying some numbing medication into the nose and then sliding a tiny camera up there and then snaking it down the throat. If you’ve cleared a drain, the action is not dissimilar. It’s not a fun, comfortable process, but I’ve now had it done a bunch of times and it’s not the worst procedure either. 

Before we left for the ER, Bess got an ENT appointment with a PA at 11:00 a.m. Great: easier than the ER—cuts out the middleman. I sent a Mayo portal message to Dr. Hinni’s account, which is usually monitored by a nurse. Dr. Hinni is the surgeon who led both my surgeries; coincidentally, I’d seen him Monday for a routine follow-up. He’d looked around in my mouth with a little mirror and said I look great. It must be disappointing to be a doctor, doing all this great work, only to have the great work you’ve done up and die on you. Maybe it’s like carving pumpkins or ice sculptures, knowing that the work is doomed to transience. Anyway, the hoi polloi like yours truly use the Mayo portal, but Bess is among the exalted elect who work for Mayo, and on whom the Mayo light shines down always, so she sought her favorite backdoor: she checked Microsoft Teams, that blesséd communication tool of Mayo insiders, and saw that Dr. Hinni’s PA, Tony Mendez, was online, so she shot him a message, along with the photos showing what had come out of me. 

Tony replied within a few minutes saying we could come right in, but Bess didn’t see that message, so we went in for the 11:00 a.m. appointment. Fortunately, Tony was available then, which matters for continuity of care and speed of care, since he’s already familiar with me and my many maladies. We’d have a lot less catch-up with him than with someone new. 

Tony scoped me, as expected, and the scope didn’t show much; he didn’t even spot the fangs that I of course don’t have. He saw some granulation tissue in one or two spots, which indicates something healing or scabbing over. Granulation tissue is relatively good, Tony explained, because tumors don’t granulate over. Tumors just cause more problems, and it didn’t immediately appear like a tumor was pushing into my throat. It does not take advanced degrees to know that is good.

He pressed firmly on each of the tumors on either side of my neck without warning (what is it with medicals poking you without telling you first?) while the scope was in my throat, and he was relieved to see that the necrotic tumor tissue that’s been draining out of the left side of my neck since the events narrated in “What in the hole is this? A medical mystery story” wasn’t draining inward. One side of the throat showed some peculiar ridges that could be the result of a tumor pressing in, but that could also be from any number of other things, including a problematic hyoid bone. A hyoid bone horn could be poking in. That day I learned that not only rhinoceroses, Satan, and brass instrument sections have horns: the hyoid bone does too. 

Not finding active bleeding was good, but Tony was concerned that an artery could be leaking blood. The lingual artery ends prematurely and was cauterized as part of the massive May 25 surgery, so it was a prime candidate. In medicine there’s a term called a “sentinel bleed,” which basically means a relatively small bleed from a vessel that precedes a massive, very dangerous bleed from that same vessel. It’s like noticing a small leak in a submarine and going, “That leak is not likely to stay small.” It’s like hearing the floor creak in a horror movie moments before the jump shot of the monster bursting forth from the closet. It’s like all sorts of terrible metaphors—the sound of shattering glass, a strange flash of light, the sudden smelling of toast— that would make you say “huh, that’s strange” before everything collapses.

Anyhow, metaphors aside, sentinel bleeds can happen with aneurysms in particular: a little blood in the brain causes a headache, and that precedes the fatal aneurysm. If you ever suddenly feel “the worst headache of your life,” get you to an ER ASAP and tell the triage nurse “I’m feeling the worst headache of my life,” cause it might herald an aneurysm.

In my case, Tony wanted to check for bleeding with a contrast-enhanced CT scan, that would make the vessels light up and reveal any leaks or signs of a tumor eroding into the vessel. He didn’t think that such a bleed was likely, but it was possible, and fatal if it occurs. Catching it would allow emergency surgery to tie off or attempt to cauterize the vessel, or, more likely, to give interventional radiology a chance to perform an “embolization,” in which they use a catheter to seal off the vessel with a coil or some kind of plugging material (I am told that “spackle” is not the correct term). Even so, the surgery or embolization could fail because tissue behaves badly secondary to radiation and tumors. If I were bleeding and elected for surgery, I might still die, but I’d have a shot. Bess and I told Tony that on Monday, Nov. 20 (that is, today), I was supposed to get some CT scans anyway, so he threw the chest and abdomen CTs on too. Why get contrast injected twice in a ~five-day span?  

So Bess and I walked to scheduling, where a nice woman named Jenny mounted a spirited effort to get me a CT scan slot. Mayo is good at many things, but getting scans done expeditiously is often not one. Jenny wore bright blue contact lenses over her brown eyes, which gave her a kind of uncanny-valley-meets-mystical appearance, and it felt a little like she’d been hired direct from Arrakis to work the Mayo front desk. She sent me to have my creatinine—a measure of kidney function—drawn by the lab, since healthy creatine levels are a requirement for receiving the IV contrast I’d require for the scans.

The only available CT appointment was initially 5:10 p.m., but Bess worked the system some by intimating, vociferously but not inaccurately, that, if I needed emergency surgery, it would be best to find out during business hours. Jenny got the Mayo Scottsdale campus to slide me in. Score! We drove over. I wanted to stop on the way at J L Patisserie for snacks,*** but J L was barely yet distinctly too far out of the way. At Mayo Scottsdale I got into the CT area quickly, although the IV necessary to deliver contrast had me crying and whimpering from the pain of needle insertion. My veins are by now well scarred: they may be prominent, but they’re horribly damaged, like some political figures. Anyway, the IV did its job and I got scanned. 

The first paragraphs of this essay relay what the scans found, since that’s the most important thing and in almost all writing, you should start with the most important thing.  People are TERRIBLE at this. I remember this conversation between Tyler Cowen and Dave Barry on the subject

BARRY: There are certain fundamental things that businesspeople have trouble with [in their writing].

COWEN: What’s the main thing they get wrong from the business mentality?

BARRY: OK, the most consistent mistake . . . not mistake, but inefficiency of business writing — and it was very consistent — is the absolute refusal on the part of the writer to tell you right away what message he or she is trying to deliver. I used to say to them, “The most important thing you have to say should be in the first sentence.” And “Oh, no, you can’t. I’m an engineer. We did a 10-year study, this is way too complicated.”

And inevitably, they were wrong. Inevitably, if they really thought about it, they were able to, in one sentence, summarize why it was really important. But they refused to do that because the way they found out was by spending 10 years of study and all this data and everything, and that’s the way they wanted everyone to look at what they did. They wanted their supervisors to go plowing through all they had done to come to this brilliant conclusion that they had come to.

Today’s top takeaway, for example, is that the tumors in my body are mostly smaller, so I lead with it. The tumors-being-smaller thing is good from a longevity perspective and alleviates some immediate logistical challenges because I’ll continue petosemtamab for two additional months, barring the unexpected. Being ill admittedly means expecting the unexpected; I didn’t have “hacking up some blood from my throat” on my expectations list for last week. The good news about the CT scans is more important than the fact that we got the results of the CT scans while we were in the parking lot of a juice place called Kaleidoscope, picking up a cherry smoothie whose cherry pieces Bess thought looked a little too much like the blood I’d brought up that morning. She thought the observation a little gross, but interesting from a thematic perspective (ER doctors routinely compare foods to things they’ve seen at work, which does not always make them popular dinner guests). 

After Bess and I got home, Tony called us to say that he showed the CT scans to Dr. Hinni, and together they traced the arteries in the neck and concluded that there don’t appear to be any bleeds there, or any tumor eroding or compressing the vessels. Great news! The radiologist, Tony, and Hinni have all looked carefully at my insides, from the outside, and concluded that important parts of my insides are likely to stay in their proper channels.

So what happened? We’ll never know for sure. Some causes could include that 1. I’ve been hacking too hard in attempts to expel mucus, or 2. the petosemtamab is affecting the skin inside my throat as well as the skin on my body, or 3. granulation tissue (which can show up even months after surgery, particularly in people who have already been messed up by radiation). Whatever the cause or causes, if the bleeding doesn’t seriously recur, then the blood I hacked up somewhat random episode in an illness that’s been a relentless parade of boredom and pain, punctuated by terrifying and annoying episodes.

Instead of doing the writing Bess and I were supposed do on Wednesday, we spent a bunch of time in the hospital. To be sure, I don’t want to sound ungrateful for that, and not dying was and is good. Things went about as well and as fast as they could have, given the circumstances. We both got lucky, and the system worked. Tony was great! As he’s been since we met him. And yet we were still gone for like six hours, taking care of business—the business, that is, of healthcare. “The more things go wrong, the more things going wrong,” which went up last week, is highly congruent with the recent episode.

That night, to celebrate the good news from the scans Bess picked up some takeout from what used to be one of our favorite restaurants, FnB, and the food was…okay. The last bunch of times we’ve either been there (Bess) or gotten takeout from there (me), the food has felt a little phoned in. It’s never been bad, but we find ourselves looking at a dish of, say, shaved kohlrabi, cheddar cheese, lettuce, and horseradish, and we think: “Well shit, we can make that in a few minutes and for a lot less than $20.” The food used to be consistently magical, and in the last, I don’t know, six months, maybe more, it’s been less exciting. By now it’s hit that nexus of “less exciting” and “more expensive” that make us look elsewhere. Bess confirms that, although the months of disappointment with FnB correlate to my months without a tongue, the food quality has declined even when the dishes are eaten with physiologic structures intact. The Arizona challenge remains, however, in that there aren’t a lot of good or even interesting-looking restaurants, let alone really good ones, let alone great ones. I may have spent two months unable to eat via mouth, and now I can only do slurries, but I want to at least try for interesting slurries, while I can.

I have to fly to Houston on Nov. 27 to see MD Anderson on Nov. 28, and then fly home Nov. 29. Today we’re going to San Diego for a petosemtamab infusion, the week after, Houston, the week after that, San Diego again. Being sick is a full-time job—Wednesday’s adventure is thematically consistent with this—except one that you pay for instead of being paid. At least the CT scans indicate that I’ll get to spend more time with Bess, and with you, for which I’m grateful. 

If you’ve gotten this far, consider the Go Fund Me that’s funding ongoing care.


* In radiologist-speak: “New areas of nodularity and patchy airspace disease in the lung bases.” It appears that the radiologist caught two new nodules: “New 6 mm nodule in the right lower lobe” and “New nodularity and patchy airspace disease in the posterior left lower lobe.” But if a bunch are also “stable or decreased from prior,” that’s pretty good.

** That the most-efficient way to send medical imaging is still via plastic disc is insane, but that insanity is not today’s topic and it will have to wait for another time. The whole “share medical records via the EHR system” thing still doesn’t work seamlessly, to put it lightly.  

*** Bess says that I am “like a Labrador retriever in human form.” This furthers her argument, I realize. My tail does wag at the prospect of one of their chocolate cookies.

Read more: Finally, some good tumor news, but, also, hacking up blood is probably bad

The more things go wrong, the more things going wrong

When you’re robust and things go wrong, recovery happens quickly: the hamstring aches for a few days, then returns to functionality. The broken arm is an annoyance, but the cast comes off and it’s not hard to hit the gym and build back strength. The cold or flu might linger, but it dissipates. I used to be robust and, like most robust people, I unconsciously assumed robustness as the natural state of my world. Now I’m not, and the painful premature slide from robustness to fragility is foregrounded every day. After my initial Oct. 20, 2022 surgery, I recovered relatively fast; sure, I woke up with a piece of my tongue gone, but I could swallow watery smoothies the night of. I rapidly got up and walked unaided. Though the surgery aftermath and recovery were uncomfortable, I could perform the bodily functions necessary for discharge from the hospital—namely, peeing. So, I peed the night of, which got marked in my medical chart, and the day after the surgery I got to go home. I achieved independence fast.

Back then I had a lot of physical margin for illness: I lifted weights, I didn’t eat much sugar, I used a Levels Health glucose monitor (rice is much worse for glucose levels than I’d realized). The surgery could have been much harder and thus the subsequent recovery harder, but it wasn’t and my baseline level of health made me better prepared than if I’d ignored nutrition and motion. I had some social margin, too: I was in a relationship with my now-wife, Bess,* who helped tremendously: it’s hard to do life alone, and it’s harder still when sick.

Bess was there when the news came down that the tumor showed bad features, like “perineural invasion” (PNI) and “extension through the base of the mouth into the geniohyoid,” and I got assigned radiation therapy to the head and neck. During the roughest stretch I was taking 10 – 15mg of Oxycodone every three hours, on top of gabapentin,** Tylenol, and ibuprofen. Yet I’d prepped for radiation, too, as best I could: I resumed going to the gym as soon as I could, and I ate as much as I could get down in order to try gaining weight.

During an education session about the radiation process, Dr. Patel, the radiation oncologist, emphasized the need to conscientiously comply with radiation mitigation strategies and avoid, if possible, hospitalization for radiation side effects. He said something interesting—well, he’s an interesting person who says many interesting things, but this one stood out—the people who wind up hospitalized and struggling are usually the ones who are alone. No one is watching and helping, and they consequently don’t have the strength or ability to mitigate the potentially devastating radiation side-effects. Having stumblingly endured radiation with help, I see how and why someone without help wouldn’t be able to do all that needs to be done. Apparently, there are a lot more of those people than I’d naively thought. The articles and books about the increasingly loneliness and disconnection of Americans are manifested in the healthcare system.

During radiation I suffered from many maladies, but not loneliness or lack of aid. Bess, for example, made me a steady diet of Kodiak Cakes and smoothies. The Kodiak Cakes were the unanticipated, relatively high-protein staple of my diet. Usually I cook, but Bess ensured that I ate even when the thought of food made me feel a range from “ennui” to “dread.” Thanks to Bess and my family, I had not only the physical robustness, but some social and financial robustness, too.

When you’re fragile, one thing going wrong cascades into other things going wrong. That first cancer surgery wasn’t pleasant, and I wouldn’t recommend it to friends, but it was successful, in that Dr. Hinni, the ENT who performed the surgery, got clean margins and removed lymph nodes (none cancerous) from the left side of my neck. The radiation series left me with a literally stiff neck and other weaknesses, but, as I wrote in “Life, swallowing, tasting, and speaking after a total glossectomy (meaning: I have no tongue)” the damage leaned cosmetic more than structural. I tried to recover from the radiation, and I did well enough to teach an English class that began the first week of February, 2023.

In Antifragile: Things That Gain From Disorder, Nassim Taleb claims that “Some things benefit from shocks; they thrive and grow when exposed to volatility, randomness, disorder, and stressors and love adventure, risk, and uncertainty. Yet, in spite of the ubiquity of the phenomenon, there is no word for the exact opposite of fragile.” He’s right in that “Some things benefit from shocks” (emphasis added) but, if the human body benefits from the shock of having part of one’s tongue removed, and then radiation therapy, I’m not aware of it and haven’t experienced any benefit. Some stressors, like the squat and deadlift, are good for the body. Others, like tongue removal or chemotherapy, are not, though they’re better than cancer. Taleb says that “Complex systems are full of interdependencies—hard to detect—and nonlinear responses.” Cancer likely qualifies as the sort of thing that creates a nonlinear, negative response. Friends and acquaintances have expressed shock and worry that I’m the one who got hit with squamous cell carcinoma (SCC) of the tongue: I have no risk factors and a bunch of relatively healthy habits.

After the recurrence and the “salvage surgery” that left me tongue-less, I’ve become fragile. Immediately after the surgery, I couldn’t walk unaided, because a huge piece of muscle and tissue had been removed from my left thigh to create the “flap” of tissue that inertly replaced my tongue. A fall would likely have been fatal. The last essay I wrote, “What in the hole is this? A medical mystery story,” is essentially about the dangerous medical cascades I’m prone to. Someone poor experiences a financial shock as a disaster someone with more money can withstand or even barely notice; someone sick experiences even a minor medical problem as a disaster, because, after a certain critical mass of illness, no setback is actually minor:

As of October 20, I’ve undergone a year of medical harassment / treatment, though I’m unlikely to undergo another. I’ve been conditioned by experience to always expect a new problem. Perhaps the most recent is Augmentin causing a fungal infection in a place where one really does not want a fungal infection.

The preceding paragraph also helps explain why travel is no fun. Friends have asked if I want to do a dream vacation. I see where they’re coming from, but until recently I was relentlessly exhausted by surgery, chemotherapy, and infection. I’m doing somewhat better, but I still feel on the verge of catastrophe. Weight is part of it: I’ve lost around 40 lbs and worry about starvation. That is not a joke. Most of my calories are injected into my peg tube, and I “eat” from pouches of Liquid Hope. The TSA won’t let Liquid Hope pouches through airport security theater, so I have to check them in a bag. If I show up somewhere and my bag—containing the food I have to eat, the syringes I have to use to inject it, and so forth—doesn’t, that’s an immediate crisis. I can’t buy peg-tube food in a grocery store. If I don’t have, or lose, medications like antibiotics when I need them, that’s a crisis. I don’t know what the next potential crisis might be, but I want to avoid it. Acquiring Covid on an airplane or in an airport could result in a crisis.

Crisis, disaster: those are always lurking in my mind, sometimes consciously and sometimes unconsciously, and everything I do or, more often, don’t do is controlled and informed by the disaster worry. The number of things I can do shrinks, and the number I can’t grows. I mourn what I could do in the past and can’t now, though I seek to emphasize the positive aspects of the here and now. Fragility means feeling like my body is betraying me, every day. It’s looking in the mirror and seeing a half-dead ghoul looking back. It’s the cruelty of disfiguration. It’s the choking on food. It’s the full body rash and my skin cracking and peeling from the petosemtamab infusions, it’s the cuts on my thumbs and heels that won’t heal properly. It’s the fear of catching a cold, because I already have so many problems with mucus. It’s the social isolation, “social isolation” being another term for “social fragility,” because speaking is now so hard that casual chat isn’t casual and subsequently doesn’t happen. The words coming out of my mouth trip over each other like drunks incoherently trying and failing to get out of a car successfully.

The sick really inhabit their own—our own—world. Beyond being isolating, it’s the world of missed connections. I read the David Brooks book How to Know a Person: The Art of Seeing Others Deeply and Being Deeply Seen, and it describes the fragility of true, intimate connection and how you can miss a momentary something and inadvertently degrade the moment:

I realized that I have to work on my ability to spot the crucial conversational moments in real time. I have to learn how to ask the questions that will keep us in them, probing for understanding.

It’s easy to miss these moments in conversations with friends, and it’s almost impossible to force them. We can try to set up conditions for the crucial conversations, but truly having those conversations is unpredictable, like good ideas: good ideas sometimes arrive at the most unexpected moments, but the people who are actively seeking them out and trying to harvest them are more likely to find them. My ability to seize the promising conversational moments has been retarded, though not yet entirely eliminated. I’m still trying to have Brooks’ crucial conversations with friends, however much I sense the relentlessly missed connections. I say something that’s too garbled to be understood; my friend stops and asks for clarification; we never quite achieve the right rhythm. Brooks speaks of talking to a dinner partner who said that: “He’d be in the middle of an important meeting with someone and his mind was always going back to reconsider something that had already happened or leaping forward to think about something he had to do later in the day.” Too late, Brooks realizes:

That was an important confession! I should have stopped him to ask him how he had become aware that he had this weakness, had this flaw marred his relationships, how did he hope to address the problem?

The moment is lost to time. For me, fragility means so many of those moments are lost to time, or they never happen due to exhaustion, nausea, and the challenges of speaking at all. I try to compensate via writing, but the writing is still a compensation. Most people don’t like writing and can’t maintain relationships primarily through text. I have a few friends who are like me and can, but I recognize that that ability is rare and weird.

My life feels like it has, and I have, been reduced and reduced and reduced. One friend wrote to me that: “NO, SUFFERING DOES NOT MAKE YOU LESS HUMAN.” He’s probably right, and yet I waver in believing him. Suffering might be the human condition, the link that binds us, but in limiting the way I connect with other humans, it somehow makes me feel both far from everyone else and also further from myself. Maybe my friend is right and being human means being isolated by the unique experience of our own personal decline and mortality. We ultimately face it alone, together.

Still, it’d be nice to feel like the “together” part isn’t being degraded by my deficits. You miss something in the conversation, and that miss degrades the connection a little. The parallel to the body’s fragility is probably obvious, but, to make it explicit, fragility means that missing something might initiate a crisis that ruins your body altogether. It might mean dying. It means losing days and days to medical treatment. A single ER visit for a dislodged PEG tube, the replacement of which takes two minutes now that the tract is fully formed, still somehow eats up at least five hours of a day. That’s five hours I don’t have to spare, but at least the PEG tube replacement is a simple repair (I know: I sound like a bike in the shop). At what point is something beyond repair? At what point am I reaching the point of no return? Do you always know the tipping point? I don’t think I do, not now, but the final tipping point is close, and at some unknown, lurking point soon I’ll fall forever.

If you’ve gotten this far, consider the Go Fund Me that’s funding ongoing care.


* She has her own Substack, too, per the link.

** Gabapentin dampens nerve response and consequently has the unfortunate side effect of dampening sexual ability and response to near non-existent, so it’s testament to the discomfort of radiation that I continued to take every dose on a fixed schedule.

 

 

Check out that petosemtamab rash: apparently, most EGFR inhibitors cause rashes.

What in the hole is this? A medical mystery story

Three weeks ago, Bess and I noticed what we assumed to be three large whiteheads on the right side of my neck. “Weird,” we thought, “but the petosemtamab is provoking an acne-like rash, and whatever that is, since it looks like acne, it’s probably part of the rash caused by the drug.” I’m sensitive to growths on my neck, given that there are four or more tumors in there, and I’ve received radiation on it, and it’s been operated on multiple times. My range of neck motion is maybe 30% of what it was before cancer. Anyway, Bess and I talked to Dr. Sacco, my oncologist at UCSD, about the apparent whiteheads before the last petosemtamab infusion, and Dr. Sacco gave Bess the go-ahead to lance the whiteheads with a sterile needle.

A procedure! ER docs like Bess love procedures. She once did a thoracotomy, which requires the doctor cut through the patient’s fourth and fifth intercostal space, spread the ribs with a “rib spreader” (it is what you think), and use their hands to manually pump the heart. In movies and novels, it’s always the villain who wants to hold someone else’s still-beating heart in their hands, but in real life sometimes the heroes get to do it. Anyway, this procedure was less involved. Bess cadged a needle from an appropriate source that’ll go unnamed here and gleefully lanced me the day after we saw Dr. Sacco, cackling the whole time about how “she who wields the sword, has the power.”* I was afraid but did not die, though a bunch of gunk flowed out when Bess massaged the area after the lancing. Bess didn’t know precisely what the gunk was. It seemed thicker, more copious, and less odorous than would be expected from a small abscess. Whatever it might have been, it was out and we hypothesized that that was probably good. The experience was moderately painful, and I tried to think about other, positive things, like mild sun on the beach, or a viewquake, or nutritious-yet-tasty foods like peanut butter.

As you’d assume from a lifetime of imbibing competently created narratives, I am not in fact introducing the idea in the previous paragraphs only to let it peter out. I more or less successfully focused on matters other than my neck until a week from last Friday night, or, more technically, Saturday morning, when I woke up at 4:00 a.m. I went through the usual drink-water-and-hack-up-mucus drill, which is unpleasant but also now a consistent part of my life, and I was getting ready to inject a small amount of nature’s sleep aid into my peg tube when I reached up to scratch my shoulder and felt something wet and slimy.

Even my sleep-addled brain registered “wet and slimy” as notable. “Shit,” I thought. “What’s that?” Wet spots out of place (heretofore known as WSOP) are often medically ominous. In the bathroom, I flipped the light on, annoyed that I was probably destroying my ability to get back to sleep, but I also saw hummus-like goo along my right shoulder and neck. I understood that there was almost no way the WSOP could be hummus, which has never dripped on me from the ceiling; to enjoy hummus, I’ve always had to work for it, and I’ve never had it, or chocolate, or peanut butter, drip spontaneously on me, or from me, for my own delectable satisfaction.

“Whatever that is, it can’t be good,” I thought. I went to the bedroom and woke Bess, but I mixed up the order of things I told her: instead of saying: “I am okay, but can I show you something?”, like I ought to have, I said: “Can I show you something?” Seeing her go from “sleepy” to “alarmed” in the space of my sentence, I properly added: “I am okay.” Considering how quickly she jumped out of bed, I don’t think she believed me. She’s highly skeptical of anything that comes out of a patient’s mouth (or mine), in the manner of most ER doctors. Doctors hear too many medically implausible or impossible stories. She followed me into the bathroom and examined the WSOP running along my neck and shoulder, and she agreed that that couldn’t be good. Learning that she too thought that that couldn’t be good made me feel better about my medical judgment., but not better about the actual situation. Though it couldn’t be good, Bess also couldn’t say exactly what it was (useless ER doctors). It wasn’t fluid like pus, and it didn’t smell like necrotic tissue. It also, thankfully, wasn’t bleeding, or squirting or spurting or any other number of alarming gerunds that would have required a call to 911. She called upon her considerable medical prowess to confirm that 1. there was a small hole and deduced that 2. the small hole was where the substance was coming from. I felt reassured.

She pressed on the area around the hole without warning, also in the manner of ER doctors, to see if more would come out. More did. The mystery was at least partially solved. Apart from the hole, the right side of my neck had also been getting steadily redder over time, and we couldn’t help noticing that the redness seemed to have accelerated. Yet I was breathing, didn’t have a fever, and wasn’t showing any signs of septic shock, so a 4:00 a.m. ER trip wasn’t merited. We cleaned up the WSOP goo that had erupted from the side of my neck and went back to bed. Once we’d determined the need for immediate, emergent medical intervention wasn’t necessary, the next-best clinical step was “ignore it and go back to bed.” We’d look again in the morning.

Saturday morning, we saw that the goo had continued to leak all over me in the night. I’d gone from the general “feeling bad” that I’d been suffering to “feeling totally awful, as if I was being colonized by some alien organism.” The hole was still there and the skin around it had gotten redder and angrier, which made me think I’d have to go the ER despite not wanting to. The bottom half of my face was hideously swollen, too. Choose your animal analogy: rabbit, chipmunk, bulldog. Bess assumed a skin infection. I was wondering: “Why does this shit always happen to me on the weekend?” The peg tube has spontaneously come out of stomach twice, and both times on a Saturday, necessitating ER visits when interventional radiology (IR) wasn’t readily available to put a new tube in the hole. Going to the ER is expensive and time consuming, and it’s where the sick people are.

Bess tried to contact UCSD’s oncology department, but, it being Saturday, no one was home, so she tried ear, nose, and throat (ENT). Got a resident! He said the hummus-spewing volcano might be a necrotic, infected lymph node, and as soon as Bess heard that she realized that that read could be right. If the problem was a necrotic lymph node, that also means an abscess running deeply and dangerously into my neck was less likely. The resident asked us to send pics and said he’d call his attending, Dr. Califano,** and get back to us. Bess took a bunch of pics in which I look close to as hideous as I’ve ever looked.

Hours passed. Bess and I debated going into the ER despite having already begun the grinding of the medical gears. A CT could rule out a deep abscess, and I was feeling increasingly bad. But going to the ER sucks even if you’re being paid to work there, and it sucks worse as a patient paying to be there. Around 2:00 p.m., we got antsy and Bess called the ENT back. The resident picked up and said he was about to call us back—a likely story— to say Califano agrees that it’s likely a necrotic lymph node surrounded by a raging skin infection and that I should start an antibiotic called Augmentin.

We didn’t manage to acquire the Augmentin until 6 p.m. that night, and I injected it into my peg tube right away. By Sunday morning, I was feeling better and the swelling had declined some. Despite the experience being bad, it probably would’ve been worse if it’d happened Tuesday, when I was scheduled to fly to San Diego. I was being infused with petosemtamab on Wednesday and then, conveniently, seeing Dr. Califano for a repeat biopsy required by the study. There was (and still is) an enormous tumor growing out from the left side of my neck anyway, so I figured it ought to be easy to punch.***

“Easy,” I read in the preceding paragraph. “How much of the cancer and treatment experience so far has been easy?” I’m not a believer in fate, and yet I superstitiously felt like I was whacking Fate with a rolled-up magazine and daring it to bite me. (For once, Fate did not bite me, and the biopsy was in fact easy.)

With the infection identified—and the hummus-like WSOP determined to be whatever goo makes up an angry lymph node—I also understood why I’d been so torporous in the preceding weeks. I kept getting up absurdly late and being unable to function for hours. At most I’d have a few hours of relative energy. I’d berate myself and say: “This isn’t you. This isn’t like you. Who are you?” And then I’d sit in an exhausted haze instead of doing that which needs to be done. I read an inspiring book called Grant’s Final Victory: Ulysses S. Grant’s Heroic Last Year (you might’ve heard it alluded to in the Daily Stoic podcast), and Grant appears to have died from a squamous cell carcinoma of the tongue, caused by cigars. Grant spent much of that year writing his memoirs, hoping they’d provide financial security to his family. He and I are unalike in many ways, but this we have in common.

Grant wrote with a pen, I write with a Kinesis Advantage 360 keyboard featuring Box White switches, but the basic thrust of trying to write a memoir in hopes that it helps those who come after is similar. I get, too deeply, this problem:

Of the doctors, at this point the microbiologist and surgeon George Shrady spent the most time with Grant. He tried to keep his visits brief, because he sensed how much Grant wanted to press on with his daily writing.

Doctors back then and doctors today suck up a damned lot of time! Fortunately, my personal physician is also my best editor and reader. She is in fact reading this over my shoulder right now, as is her wont.

Anyway, Grant was worse off than me in many dimensions, and yet his writing example is one I need to better follow. The infection took a lot out of me, and Bess speculates that it was an “indolent” infection. My ears perked when she said that, because “indolent” typically means something like “wanting to avoid activity or exertion; lazy.” I’d been feeling indolent for weeks, but I’d not known that bacterial infections could also be lazy. But, ah-ha, there is a second definition! “Medicine (of a disease or condition) causing little or no pain. (especially of an ulcer) slow to develop, progress, or heal; persistent.” The infection caused little pain and didn’t progress much, thus allowing it to linger and sap me of vitality.

Being ill makes me feel like there’s always something: surgery, chemotherapy, travel, and now infection. Or maybe I should add: “and now Augmentin,” because the Augmentin is doing bad things to my stomach and digestive tract. Better than death but still frustrating. At the end of Tom Wolfe’s novel The Bonfire of the Vanities, Sherman McCoy, former bond trader and master of the universe, protests to reporters that “I have nothing to do with Wall Street and Park Avenue. I’m a professional defendant. I’ve undergone a year of legal harassment, and I’ll undergo another.” I’m now a professional patient, which is to say a professional sick person. As of October 20, I’ve undergone a year of medical harassment / treatment, though I’m unlikely to undergo another. I’ve been conditioned by experience to always expect a new problem. Perhaps the most recent is Augmentin causing a fungal infection in a place where one really does not want a fungal infection.

The preceding paragraph also helps explain why travel is no fun. Friends have asked if I want to do a dream vacation. I see where they’re coming from, but until recently I was relentlessly exhausted by surgery, chemotherapy, and infection. I’m doing somewhat better, but I still feel on the verge of catastrophe. Weight is part of it: I’ve lost around 40 lbs and worry about starvation. That is not a joke. Most of my calories are injected into my peg tube, and I “eat” from pouches of Liquid Hope. The TSA won’t let Liquid Hope pouches through airport security theater, so I have to check them in a bag. If I show up somewhere and my bag—containing the food I have to eat, the syringes I have to use to inject it, and so forth—doesn’t, that’s an immediate crisis. I can’t buy peg-tube food in a grocery store. If I don’t have, or lose, medications like antibiotics when I need them, that’s a crisis. I don’t know what the next potential crisis might be, but I want to avoid it. Acquiring Covid on an airplane or in an airport could result in a crisis. Some opportunities, if they aren’t seized in the moment, are forever foreclosed. I don’t want to sound boring, but a lot of my life entails trying to think a little ahead of health problems. For me, the best days are ones with maximum energy and minimum problems. Ideally, ones where my lymph nodes don’t explode. I hope to have more of those, before the end.

If you’ve gotten this far, consider the Go Fund Me that’s funding ongoing care.


* Okay, this didn’t actually happen, but it’d be funny if it had.

** I keep mistyping his name as “Dr. California.”

*** As in, punch biopsy. I’m not suggesting that Dr. Califano was going to punch me in the neck with his fists. He seems like a lover, not a fighter, but I can’t be sure, and will try not to elicit violence from him.

The isolating gap between speaking and being heard  

Before the massive surgery that left me without a tongue, I used to read to Bess at night to get her to fall asleep; I mentioned that practice in “I know what happens to me after I die, but what about those left behind?“:

Some books, like my copies of The Lord of the Rings or The Name of the Rose, she’ll obviously want. They’re favorites of mine, and I read both out loud to her—Bess is a nervous, difficult sleeper, and reading to her helps her relax into sleep. For The Lord of the Rings, I gave Pippin an absurdly lisping voice that often made Bess protest that I should “read him normally,” as if her nightly protests weren’t part of the fun. For The Name of the Rose, I spoke all of William of Baskerville lines in my best Scottish accent, poorly but enthusiastically imitating Sean Connery.

I got started reading to Bess when we lived in New York City and she was working emergency medicine “locums tenens” shifts* upstate, where the pay and schedule were better than the City’s. I can’t remember what inspired me, but one night we were on the phone, and I picked up a copy of Robertson Davies’ The Deptford Trilogy and began reading to her. They’re peculiar books that I shouldn’t like, about dysfunctional Canadian beta males trying to explain away their lack of libidinous zest, and yet I do: it must be the writing. Whatever draws me to The Deptford Trilogy worked on Bess too, and even when she returned from the upstate wilds I kept reading to her. I sleep readily and easily, so it was easy for me to offer up a few pages, pausing when Bess would start squawking and reacting to the story. She often accused me of inserting absurdisms into the text, and she’d insist on seeing the page itself. More often than not the text was there, but sometimes it mysteriously vanished between the moment I read it and the moment Bess looked for it.

I’d read until Bess seemed to be asleep or on her way to sleep. She finds my voice soothing, if sometimes monotone, which might be what made it such a useful soporific. The following night, I’d often have to rewind a few paragraphs to find the last spot Bess remembered. Sometimes I’d teasingly demand a summary of the previous night’s action, and express dismay if she’d forgotten key points.

Apart from Bess traveling,** sustained interruptions to the reading were rare before Oct. 20 2022, when I got the first surgery on my tongue. That surgery went relatively smoothly and easily: I didn’t have to have a “flap” composed of muscle tissue grafted onto the remains of my tongue. The surgical margins on the tongue itself were clear. I lost the lymph nodes on the left side of my neck, but none were cancerous. The day after the surgery I got discharged from the hospital. I could swallow. I don’t remember how long it took me to regain speech, but I did expeditiously, and radiation therapy was supposed to eliminate any errant cancerous cells that the surgery might have missed. I seemed to be on the road to wellness.

Regular readers know the outcome: instead of moving on with my life, the cancer recurred, a salvage surgery failed but took my tongue, and now there is a race between experimental treatments that might keep me alive for some extra months and the cancer that will almost certainly kill me soon. My body is doing poorly along many dimensions, although on a day-to-day basis I’m feeling somewhat better than I was after the savage May 25 salvage surgery, or during the two rounds of chemo.

Instead of working with my body, I constantly feel like I’m fighting it. I’ve also learned something essential about life management: I should take a sleeping aid, like Benadryl or marijuana, when I wake up in the middle of the night and can’t get back to sleep. Most nights I wake up after two to four hours needing to clear my airway of mucus, a violent, noisy act not conducive to gliding back into a relaxing bed. Too little sleep leaves me half alive in the morning, and then in a gray fog all day, and thus not very communicative. Speaking demands a lot of conscious attention in a way it didn’t used to, and when I’m already exhausted I find generating that speech hard. It’s difficult to have positive overall days without enough sleep. Bess has offered to read to me at night, but being read to doesn’t hold the same appeal.

Today I can speak again, after a fashion and with that conscious attention I mentioned, though I can tell that people hear me and wonder if I’m mentally disabled. My voice has that “is this guy okay?” quality. I used to pitch clients over the phone, but, even if I somehow, improbably live long enough for work to become an issue again, I won’t be able to. Not easily, and not without warning clients that I don’t have a tongue and sound very strange. A lot of life has been digitized, but the internet hasn’t fully resolved the problem of people wanting to have an actual conversation before they wire five figures to someone who is scarcely more than a website and phone number. Pitch calls offer the opportunity to showcase skills on the fly, too; I’ve learned enough about batteries, geothermal energy, and related topics to tell war stories about past jobs. But for me, most conversations with new people entail a lot of them saying “what?” or “can you repeat that?” A lot of them pretend to understand. I’ve gotten used to incomprehension in casual contexts, but incomprehension in business contexts means not making the sale. Who and what am I then?

The main type of person I run into who is impressed with my ability to speak is ear, nose, and throat surgeons. Them, and head and neck cancer oncologists. Those two groups understand that, relative to most people who have their whole tongues removed, I sound great! Spectacular, even. Drs. Hinni and Nagle, who removed the tongue and constructed the “flap” that I now have in place of a tongue, did incredible work. I’m their Statue of David, their Sistine Chapel. Their artistry is to be commended and appreciated. Even Jessica Gregor, the Mayo Clinic speech therapist, was amazed by my oratorial prowess at our first post-operative session, although “prowess” may be too strong a word for “being more than vaguely intelligible.” But she sees a lot of glossectomy patients and so knows the range of outcomes far better than me. I thought she was just being kind and optimistic, but it turns out the vast majority of patients struggle to be understood even by those closest to them. But to the non-cognoscenti, when I start talking I can see the “Is this guy developmentally disordered?” question being silently asked. Almost any ambient noise renders me incomprehensible. A shop or restaurant plays music? Forget it, no one will understand more than a few words I manage to emit, in my turkey-like gobble.

Technology can ameliorate the problem a little, and apps like Speechify can translate text to voice in a way that mimics natural speech and intonation. Those apps can even recreate famous voices. Maybe I would actually increase client retention if I used the “Snoop-Dogg” voice for business. More realistically, I find myself wondering what work and career might look like if some miracle clinical trial drug combination manages to keep me alive, against the odds, for years rather than months. I should’ve gotten disability insurance, but it’s too late for “should’ve.” It’s not my nature to give up, yet right now I also don’t see a great path forward. The past me is gone, and now I have to deal with the present me, however broken I may be.

I halfheartedly tried voice banking before the surgery. There’ve been clunky, inefficient programs around for ALS patients for the last five years or so. But “voice banks,” which make recordings of specific phonemes via scripts you read aloud and recreates a voice that sort-of sounds like you tend to stutter and sound robotic. I also didn’t prepare for losing my tongue and didn’t expect to lose it. The night before my unexpected total glossectomy, I downloaded one such voice bank app but only had an opportunity to record 100 sentences—enough to sound slightly like I was trapped in a computer but couldn’t get out. It was a little uncanny valley, a little horror flick, and too slow to be useful. Apple is coming out with an app soon that’ll do the same thing, and if it’s based on voicemails and recordings, that could conceivably help.

None of these programs help with inevitable latency. Latency kills the cadence of a conversation. Good conversation is a delicate thing; great conversation even more so. I’ve tried to converse vis keyboard and speech-to-text, but the rhythm is almost always all wrong. A sympathetic friend and I can do it, but we’re people who, instead of dancing, keep walking into each other and falling into holes. Just as losing my ability to eat disconnects me from a key part of the human experience, so too does losing the ability to have a simple conversation.

I can still read a little bit to Bess. Though it’s painful to ask the muscles of my mouth and throat to strain and move so strangely by speaking, it’s probably good for me to keep exercising my voice, particularly in a world where my universe has shrunk so much. Many sick people report shrinking universes, and I’m among them. The shrinkage is everywhere except for medical appointments: I don’t teach undergrads any more; I don’t pitch clients; I rarely catch up with friends on the phone, because I’m so hard to understand; even issuing commands to my car via voice, like “navigate to Sky Harbor Airport” doesn’t work. For some peculiar reason, the car has always preferred spoken commands from Bess, even before the surgery. A bunch of phonemes are still hard or impossible for me; “k” sounds, for example, I can’t enunciate. “L” and “w” are also tricky. A lot of people smile and look at me blankly when I speak, clearly unable to interpret the sounds, but not wanting to admit it. Interestingly, the group that seems to best comprehend what I’m trying to say seems to be people who work with a lot of international talent and who are thus used to a variety of accents. I did appear on The Daily Stoic podcast, which is fun, and that podcast gives you a sense of what I sound like. Bess thinks that I sound clear and intelligible.

In “How do you say goodbye?” I said:

Bess hears subtleties in my voice that I feel are overshadowed by the struggle of enunciating the phonemes themselves, especially with no tongue to help me phonate. Bess hears me more than anyone else and understands the sounds I emit better than anyone else, through pure exposure. Much like parents can understand the seemingly unintelligible squawks of their toddlers via practice and exposure, Bess will translate what I’m saying to those who can’t make out the syllables I’m trying to pronounce. How are they supposed to understand my tone when they can hardly understand my words, garbled by a lack of tongue? Somehow, Bess can. Further complicating the difficulty of saying goodbye is the physical challenge of speaking.

Last night, I tried reading to Bess before bed. She was feeling antsy, and we were halfway through a copy of Elmore Leonard’s novel Be Cool before the surgery, so I picked it up. She lay there with an eye mask on her eyes and the half-smile she gets when she’s expecting to be entertained. I did the “Chili Palmer” voice the best I could—a staccato, sort of hyped-up New Jersey Sopranos reject-actor voice. Bess laughed at me. She’s reliably amused by the absurd voices, although the one I do for Chili Palmer isn’t as mirth-inducing as the one I did for Pippin.

One of the great things about Bess: if I find something that makes her laugh, I can just keep pushing that same button, seemingly forever, and she’ll enjoy it every time. Bess followed my reading, though, or seemed to, and when I switched to a female character she noted, amused, that “every woman you’ve ever read to me sounds the same.” Which felt like a ridiculous thing to say—of course I don’t sound the same as I did, and my female characters must sound different too. I have no tongue. My words slurred and I strained. But Bess has said she doesn’t see me like a cancer patient most of the time, and so perhaps she doesn’t hear me as one either. I’ll never sound “normal” again, and probably I’ll never meaningfully work again, but, at least with Bess, I know she listens when I speak, which makes a difference in helping to just feel like, well, myself. Maybe it’s not principally how you speak that matters: maybe it just helps to know that someone really hears you.

If you’ve gotten this far, consider the Go Fund Me that’s funding ongoing care. If you or someone you know is going through cancer and needs to understand the clinical trial process, this is what happened to me.


* I don’t know why the absurd Latin phrase persists in the field, apart from path dependence, but doctors who work “locums” shifts aren’t employed full-time at the hospital. A placement agency usually finds the docs, qualifies the docs, and gets the docs credentialed at a given site. Since there’s a shortage of doctor and residency slot because of the lobbying from the American Medical Association (AMA), docs get higher pay than they would without that shortage. Most docs don’t suffer through four years of med school and three or more of residency to live in rural areas, so rural areas are continually importing docs from fun cities.

** She frolicked at Burning Man one summer, and I didn’t read to her at all while she was there. In retrospect, I should’ve recorded a couple hours of book and told her to listen to 10 or 15 minutes a night.

How do you say goodbye?

I’ll admit a disappointing answer up front: I don’t know. Because I’m dying, I’ve been saying goodbye a lot, but even after a bunch of practice I still don’t know how to say it. Humans have to learn how to say all sorts of unpleasant and unhappy things; as I write this, terrorists have broken into Israel and murdered hundreds, if not thousands, of civilians. Someone will have to call their families and say: “Your brother | sister | son | daughter | cousin | friend is dead.” One Israeli 13-year old’s whole family was murdered. Someone had to tell him. And then time continues its perpetual beat, and the people who’d been living and animate will transition from the small percentage of humans who are alive to the much larger percentage who are not. I get the relative luxury of saying goodbye, of thinking about how it should be done.

I wrote in “How do we evaluate our lives, at the end? What counts, what matters?“:

One estimate finds that about 117 billion anatomically modern humans have ever been born; I don’t know how accurate the “117 billion” number really is, but it seems reasonable enough, and about 8 billion people live now; in other words, around 7% of the humans who have ever lived are living now. I’ve had the privilege to be one. At current levels of technology, however, the gift must be given back, sooner or later, willingly or unwillingly, and sadly it seems that I will be made to give it back before my time. I have learned much, experienced much, made many mistakes, enjoyed my triumphs, suffered my defeats, and, most vitally, experienced love. So many people live who never get that last one, and I have been lucky enough to. The cliche goes: “Don’t be sad because it’s over; be happy that it happened.” That is what I’m trying to do, at some moments more successfully than others. I try to focus on those ways I am so lucky and blessed, but I am often failing.

Despite not knowing how to tell people I’m dying, I feel like I have to, because the alternative is worse; I’ve heard of cancer patients who tell no one, and then the shock strikes their friends and family at the end. All else equal, I prefer to do it via essay: one gets a fullness and richness that speech or text message seem to lack. There’s a consistency, too, when sharing the same document with friends and family, in that everyone I love understands what I’m thinking and feeling. Probably I should read these essays aloud and upload them. Overall, I’ve learned to do it plainly and straightforwardly, if possible. It’s a stunning blow to most people who know me, but it’s better delivered with minimal rhetorical cover. Then there is time for the rest. I’ve told many people that I’m dying and yet I still feel like I’m no good at it.

I may have learned this “do it now, and fast” lesson from Bess: she told a story called “How to say it,” in which she describes her (sadly extensive) experience in telling people grisly news: your abdominal pain isn’t gas, it’s cancer; the cancer you thought you’d defeated is back and has metastasized everywhere; the infection that was in your bladder is now in your blood; there is nothing more medicine can effectively do for you other than refer you to palliative care; and, most notably, with declaring death:

I take your family to a quiet room, with Kleenex. Then I say the word “dead.” Not “expired,” because you were a person, not milk. And not “passed on,” because families always want to believe you were just transferred to another hospital. “Dead.” I have to say it.

That’s all they really taught us in medical school about how to deliver bad news. A one-hour lecture. So we learned by watching our teaching physicians. We were their constant audience in a sort of theater of the bereaved: lurking near doorways and family rooms and the hospital’s ER, noting how soft they made their voices, when they patted someone on the back, how much technical jargon did they use before getting to the word “dead.”

When you train to become a doctor, they don’t really teach you about death. They tell you how to prevent it, how to fight it, how to say it—but not how to face it.

Doctors are often the border agents of life and death. A lot of modern, industrialized people, like yours truly, don’t have a lot of direct experience with birth and death. Fertility rates are tragically low (housing prices and exclusionary zoning stifle them), and most of us avoid death where we can. My family is tiny, so I missed the passing of elderly relatives when I was young. Bess is an emergency medicine doctor, though, and so she often has to say it. The word “dead” is key. She doesn’t take on the emotional challenge of the dying, though, because to do so would render her ineffective at preventing premature death as best she can:

The first time I had to be the one to break bad news to a family, I was in my last year of residency training. I remember having to do it in the patient’s room, because his adult daughter refused to leave his bedside. So I said, “I’m sorry. He’s dead. We did everything we could.” Then I was supposed to give her a few moments alone, but I was paralyzed. Rooted to the spot by a feeling of failure and loss. When I looked at the bed, I was imagining what it would be like if that was my father. My supervisor must have realized what was happening, because she grabbed me by the arm and dragged me out the door.

“Don’t you ever do that again,” she said. “Don’t pretend that grief is yours when it’s not. One day, you’ll be where she is. But if it’s not the person you love on the table, say you’re sorry, mean it, and then you have to walk away.”

Her emergency medicine attending physician was right, and now Bess is, in a sense, where that patient’s family was. At work, she’s learned to deliver the bad news calmly but firmly, stamp out any ill-conceived hope born of desperation, and offer to get social work or the chaplain in to help the family. Then she goes onto the next patient, who might have come in for something as minor as an ingrown toenail. Their grief can’t be hers. Patients who get bad news about cancers get passed to oncologists, who have to be tragically familiar with saying goodbye. Lots of doctors have to figure out how to say it.

I like the way Dr. Hinni did it: when I got the horrible news about the recurrence, Bess or I texted him with the news. Telling him seemed polite: he’d done so much impressive work on me, and so we thought he’d want to know how the story turns out. We messaged him on Friday, July 21, and the first chemo round was scheduled for Monday, July 24. Our friend Fiona flew into town for it. Dr. Hinni must either not have been operating that day or had a relatively minor operation—I was once, in October 2022, a relatively minor operation by his standards—because he stopped by in the afternoon. I was snowed under by anti-nausea drugs and so was asleep when he got to the infusion center; I woke up and said hi. He may have been holding Bess’s hand. He came over and held my hand and said he was sorry. I understood: he’d done everything he could.

I asked a futile question I was pretty sure I already knew the answer to: “I assume there’s nothing else to do surgically, right?” My neck already felt like I was in a tight noose. The first surgery and then the radiation had taken so much out of me. The second surgery felt like it had taken whatever margin was left. Dr. Hinni confirmed that, no, he couldn’t do anything more: any attempt to remove the tumors would likely spread them further. He understood, and I understood. I don’t know how long he’s been a surgeon, but I have to think he’s in his 50s, and thus he’s seen a lot of patients whose cases didn’t go the way he’d like. Beyond the confirmation of the obvious and the statement that he’s sorry, there wasn’t much to say. There was the comfort of a hand being held, and the sense of tragedy, and then he wished us well and went out into the world, to help those who can still be surgically helped.

There’s something to the low-speech approach.

“Words are inadequate” many friends and acquaintances have (correctly) said to me; they know I’m a writer, but I don’t think that’s why they say they don’t have the words. I agree with them about how there are no words, apart from the simple and elemental ones, like “I love you” or “I know I will be gone, but I will also miss you.” The big elemental feelings don’t handle contractions, I guess. Maybe that’s one way to say goodbye: with fewer contractions, and more feeling in the voice. “Feeling in the voice” is hard for me, because, without my tongue, I sound like a goose being strangled whenever I speak, or a trumpet manipulated by a poor musician.

Bess claims that I actually have more vocal modulation now than I did before, an assertion I’m extremely skeptical of. She says—and I mostly deny—that I had a tendency to be monotone, responding often to her sharing of exciting news with the reply, “great,” said in a tone similar to that of someone learning their sexual prowess is best described as “resoundingly okay.” Bess further claims she could identify my emotional timbre based on other cues, but that vocal tone was never my primary form of emotional conveyance.* Yet back when I still had a tongue and read novels to her at night to help her sleep, the voices that I gave to the characters often made her laugh. (“Yes, but you made their voices purposefully different than your personal default,” she protests when she reads this.)

The point is, even today Bess hears subtleties in my voice that I feel are overshadowed by the struggle of enunciating the phonemes themselves, especially with no tongue to help me phonate. Bess hears me more than anyone else and understands the sounds I emit better than anyone else, through pure exposure. Much like parents can understand the seemingly unintelligible squawks of their toddlers via practice and exposure, Bess will translate what I’m saying to those who can’t make out the syllables I’m trying to pronounce. How are they supposed to understand my tone when they can hardly understand my words, garbled by a lack of tongue? Somehow, Bess can. Further complicating the difficulty of saying goodbye is the physical challenge of speaking.

There’s the difficulty of how to find the right words to say goodbye and the things that I don’t want to leave unsaid before the end. Maybe my struggle with physical speech is one reason I feel like I get closer to the core of what I’m trying to say when I write the email updates to friends and family—or these essays. I don’t have to stop to repeat myself, or have Bess explain what I said, or manage the frustrations of premonitory small talk (a while ago, I declared a “moratorium on banality”). Speaking is also physically painful, and although I have a “use it or lose it” approach, there’s still an opportunity cost to conversation. Writing the right words also means that the people they’re intended for can read them now, and again later, whether I’m here or not. They’re less ephemeral than a chat, though I’m aware too that they often don’t generate the same feeling as spoken speech. Yet some written words generate a lot of feeling; for example, Bess has a little shoebox in which she’s kept every card and note I’ve ever written for her. I imagine she’ll go back to those in the years to come when she wants to feel my love for her. She’ll probably re-read these essays too, as they’re a kind of summa of my life and feelings and sensibility. Textually, there will always be a chance to have another goodbye, in a way that spoken words can’t achieve (unless they’re recorded, I guess). My words might be inadequate, but having them is still better than not—both for me and for those who I leave behind.

There are other ways I’ve tried to say goodbye: I’ve been making videos for Bess. She’s given me a list of things she things she thinks she’ll need to hear (figuring out what those things might be is a harder project than she anticipated), so that she can pull up one of the short videos I’ve made for her on the topic and listen to it when she needs to hear me and hear me telling her she can do it. I’ve made videos for when she’s feeling lonely, or when she needs encouragement, or when she can’t sleep.

My siblings asked for a copy of my signature, and then tattooed it on their forearms so that I’m somewhat literally “signing off.” Rachel and Sam say this way, I’ll always quite literally be with them.** And this month, Bess and I are (hopefully successfully) making embryos for IVF so that, while I am taking leave of this life, we’re also making a new one and sending the beauty of human consciousness into the future. This is a particularly hard way to say goodbye, but it’s also a hopeful one. There’s a future to look forward to, even if I’m not in it in the way that Bess and I anticipated, or hoped.

There are probably more ways to say goodbye that I haven’t tried, or thought of, and I’m open to hearing what people need. If friends and family have something in particular that would satisfy them, and I can manage it, I’ll do it. Saying goodbye isn’t something that I have to figure out solely by myself, even though I’m the one going. I said in the essay about psychedelics easing the path to the other side that I find myself comforting others about my impending demise more than I get comfort from them. Goodbye could be the opposite: I take more than give. Goodbye is relational. It’s something that is figured out between myself and the person—or people— I’m saying it to. Death is forever, but the memory of me and of saying goodbye will live on as long as the people I have known and love do.

So that’s my take on how to say goodbye: I said I don’t know at the start this essay, and I still don’t (really) know at the end. If you know, let me know. I’ll be here for a bit, but soon I’ll be saying those truly final goodbyes and then it will be too late. So don’t wait: I don’t have time. Could be that you don’t, either. None of us do, not really, which is why you should do the thing you’ve always wanted to do while you can (provided it doesn’t harm other people or have significant negatives). On July 21, I didn’t know whether I had only weeks left to live, and so maybe I jumped the starter gun on saying goodbye. But I wanted to tell the people who are important to me what I felt while I could. Tell people you love that you love them. Encourage them to live in blessedness and to live generative lives. Doing so won’t take many words, but “I love you” is what matters, in death as in life.

Maybe goodbye is not really something that’s said, but something that’s done, and I’m trying to do goodbye, which seems to be done most often speechlessly, sitting with people, our thoughts on one another but few words coming out, because those words don’t work. I’m reminded of a scene when, at the end of The Lord of the Rings, the elves are passing out of Middle-earth forever, and with them will go Gandalf and many fair things and the memories of the Elder Days; after the fall of Sauron, Celeborn and Galadriel are traveling with some of the remaining Fellowship members:

They had journeyed thus far by the west-ways, for they had much to speak of with Elrond and with Gandalf, and here they lingered still in converse with their friends. Often long after the hobbits were wrapped in sleep they would sit together under the stars, recalling the ages that were gone and all their joys and labours in the world, or holding council, concerning the days to come. If any wanderer had chanced to pass, little would he have seen or heard, and it would have seemed to him only that he saw grey figures, carved in stone, memorials of forgotten things now lost in unpeopled lands. For they did not move or speak with mouth, looking from mind to mind; and only their shining eyes stirred and kindled as their thoughts went to and fro.

I’m not a grey figure carved in stone or a memorial of forgotten things now lost in unpeopled lands, but this part of my life feels a lot like a living memorial to the rest of it. Though Bess and I are, hopefully, starting vital new works, there’s a strong sense that I have far more past than future. A miracle is possible, but I’m assuming I’ll remain in line with the statistics describing my disease progression. And so I’m trying to say goodbye, even if that speech is often done not by speaking from the mouth, but by being with friends and family and each of us looking from mind to mind, and wishing that the end were not here so prematurely.

Sometimes words work, as when Bess and I sealed our covenant with “I do” before the night of the total glossectomy surgery that she justifiably thought might take me from her forever. It didn’t, though, and that’s why we’re in what soccer fans call “added time.” Or, as I’ve been calling it, our “bonus time.” Time I’m using as best I can, despite the sense that the words “as best I can” still aren’t adequate, and the cruelty of premature departure cannot be assuaged.

If you’ve gotten this far, consider the Go Fund Me that’s funding ongoing care.


* Often I show affection via cooking: that I can’t eat anything apart from blended slurries hurts particularly in my case.

** My brother, Sam, wrote this:

The location itself was also deliberate, at least for me. Those who survived the Holocaust often pointed to their arms when saying “never forget.”

When people see my right arm, they often ask: “What’s the meaning behind those tattoos?” And I tell them: one of them is the Tree of Life encircling the world, and the other is the Seed of Life from sacred geometry/eastern mysticism. The theme of my tattoos on my right arm was always supposed to be representative of life. But there is no life without death, and now I have your signature there too.

When people ask me, “what’s that scribble on your forearm?” I can now answer: my brother’s signature. And then I will tell them about you, who you are (were), who you aspired to be.

I guess it’s my way to never forget.

How do you say goodbye

The characteristic petosemtamab rash covers my face; a tumor is visibly erupting on my neck.

“Forever is such a short, long time”

Forever is such a short, long time” is Bess’s latest essay. It starts this way:

Jake and I look at each other and say, “I will love you forever.” But Jake is dying of a squamous cell carcinoma, so while “forever” is supposed to be a very long time, our actual time horizon is so very short.  

We married on May 24, 2023, the night before a huge surgery that was supposed to cure his recurrent squamous cell carcinoma of the tongue. Our impromptu wedding was in the courtyard of our apartment building, beside the empty pool, and underneath a second-floor stranger’s patio; we’d chosen the spot because those neighbors had had fairy lights strung up for ambience. In the background, in lieu of a string quartet, were jokes and distorted laughter from a drag queen hosting bingo across the street at an open-air bar called The Hot Chick. Our friend-slash-quickly-ordained-online-officiant Smetana had to raise her voice to recite the ChatGPT-composed ceremony (she did a beautiful job).

We didn’t have rings to exchange because we hadn’t yet bought any: Jake’s surgery had been scheduled for June 8 but was moved up, probably because his surgeon, Dr. Michael Hinni, thought Jake might not make it to June 8. I worried about the same issue, because Jake was getting visibly, alarmingly worse day by day. I’d been watching him, as a doctor and wife, and I didn’t know whether he’d make it through the surgery (or the night).

Read the rest.

The body’s betrayal and the struggle to gain weight

I stand on the scale and it flashes 137.8 lbs, which elicits cursing because 137.8 lbs is dangerously low and I’ve been trying, futilely, to gain. Though I’m dying at an accelerated rate from metastatic squamous cell carcinoma of the tongue, inadequate calorie intake risks accelerating the death timeline, which makes the day-by-day eating stakes high. Most of us eat in ways that are optimized for pleasure and convenience, not longevity, and we eat too much food because it’s delicious. When we down that extra bowl of pasta and grab that cookie, we don’t think those choices will be fatal soon. For me, though, there’s a tight feedback loop between missing scheduled calorie intake and hitting a dangerously low weight that leads to body shutdown.

I have to remind myself that missing meal injections—most calories are infused into my body via a peg tube that inserts directly into my stomach—will quickly become a serious problem. Chemotherapy especially leads people to under-eat, and, while I don’t have more chemo immediately scheduled, I’d be surprised if I’m totally done with chemo. Surgeries and chemotherapy have, together, severed much of the mind-body connection between food and me, and the results are weird, since I don’t feel hunger despite losing weight. Most of us, I think, live within some kind of tolerable harmony with our bodies, as I did prior to losing my tongue and neck lymph nodes and much else; instead of fighting some external foe, I feel like I’m constantly fighting myself—and losing.

I feel like I’m losing against my body and slowly losing my ability to live. A year ago I weighed 175, but since that time I’ve been sliding into the abyss of illness. Though I try to get out, each step is like a step into scree, such that even the efforts to get out of the abyss merely causes me to slide further in. It’s a peculiar experience: one day, before the first surgery, I’m healthy, and then there’s a brief interregnum (like, I imagine, a city that knows the war will soon arrive), and then, because of the surgery and recovery time and subsequent treatments, I’m never healthy again. There are a few moments when I seemed to be improving, but never back to the pre-surgery baseline, and my new “baseline” keeps changing for the worse after each major surgery or new treatment. However much I try, cancer and responses to cancer beat me down and make a normal relationship with my body a memory.

I got diagnosed with squamous cell carcinoma of the tongue in Sept. 2022, followed by the removal of the initial 9mm tumor on Oct. 20. Radiation therapy followed in December and January; radiation therapy didn’t work but, predictably, caused unwanted weight loss. That weight loss wasn’t so big a deal until a routine PET scan on April 26, 2023 showed a hot spot in my neck that eventually and tragically led to a total glossectomy (“total glossectomy” is the fancy medical term meaning “removing the whole tongue”). During cancer and similar medical maladies, many if not most people feel their body is betraying them, and I’m not excepted. Until that total glossectomy, I managed to maintain weight effectively enough given the circumstances.

The total glossectomy surgery was an order of magnitude worse than anything I’d ever been through, and I didn’t expect it, either: I thought I would lose half my tongue, not the whole thing. But the tumor had burrowed into the blood vessels in my tongue, meaning that the whole organ had to go. The surgery’s immediate aftermath was and, as of this writing, still is the darkest period of my life; during the first recovery week in the Mayo post-surgery ward, I felt like I should be dead despite being technically, formally alive. The sense of living death made me not want to exist at all. When I went into the hospital on May 25, I was close to 160 lbs, despite that radiation treatment on my head and neck. I apparently did relatively well at radiation (I say, as if it’s some personal virtue rather than random chance): the inside lining of my mouth, tongue, and throat didn’t slough off, and, with enough oxycodone and viscous lidocaine for the mouth, I could eat some chia pudding and some Kodiak cakes dipped in maple syrup. To the surprise of the radiation oncology team, a few solid or solid-ish foods were easier than smoothies, which burned.

Between January and May I tried to eat more than I typically would, and I trained with barbells, yet I didn’t gain much weight. I wasn’t worried, though, because the ear, nose, and throat (ENT) surgeon who performed the October surgery and the radiation oncologist who supervised what you’d expect given his specialty thought I was cured. I assumed they, and the Mayo Clinic tumor board at which my case was discussed, would be right. I’d not read things like this: “Most patients are diagnosed with a locally advanced disease and treated with strategies integrating surgery, chemotherapy, and radiotherapy. About 50% of these patients will experience a recurrence of disease.” I’m not sure what qualifies as “locally advanced,” but, although my tumor showed evidence of “perineural invasion” (meaning: it had invaded nerves in the tongue), it hadn’t spread to lymph nodes in the neck. I was considered stage 2, only because the tumor very slightly extended into the floor of my mouth. Not all news from the first surgery was good, yet my presentation wasn’t as bad many people’s, and I didn’t realize that recurrence is more common than I’d been led to believe.*

By the time I got out of the hospital on June 5, after 11 days and without a tongue, I weighed just 146 lbs. Getting calories in was that hard. For the first days after surgery, a tube went in my nose and into my stomach, and an edible food-like substance called “Nutren” or “Nutren 2.0” could be injected through the nose tube. Being fed through the nose is as comfortable as it sounds, and injecting food that way reliably triggered nausea, even with zofran, so I didn’t get many calories. Imagine the feeling of swallowing nasal backdrip as the only way to access nutrients and you’ll have a sense of the “nasogastric tube” diet experience. Early on, too, I was just barely hanging on, and food injections weren’t a top priority. Maybe a week after the surgery I got a PEG (percutaneous endoscopic gastrostomy) tube placed in my stomach, but the nausea persisted—I think I’d gotten out of the practice of eating.

Once I got out of the hospital, the Case Managers at the Mayo Clinic Phoenix, where I was being treated, couldn’t get me the infusion pump I needed, and Bess and I made a critical mistake in not buying one ourselves. For vital equipment, I discovered the hard way that it’s better to buy an extra one than risk not having it. A “Moog Infinity Pump” is the right pump, it turns out, and costs about $600—yet it took us two weeks to get one. The ordeal of getting out of the hospital with a new PEG tube, a tracheostomy tube, and limited preparation for everyday life is too long and elaborate to get into here. But during those two weeks I wasn’t getting enough calories, and I dropped to around 137 lbs. Each drop seemed shocking and dangerous—how much more could lose before I went into organ failure? one pound? two? five?—and yet I remained corporeal. Now I’ve stabilized in that 140 lbs range—still far too light, but, for the time being, slightly functional.

Why can’t I gain weight? Bess speculates that my tumors may be highly catabolic, which means that they’re using a lot of calories and essentially stealing them from the rest of my body: “Cancer-associated malnutrition is driven by reduced dietary intake and by underlying metabolic changes (such as inflammation, anabolic resistance, proteolysis, lipolysis and futile cycling) induced by the tumour and activated immune cells.” So it may be that, just as I’m at war with my body, my body is at a civil war with itself.

I mentioned that the mind-body connection was, if not severed, then attenuated. I don’t or rarely feel hunger. I don’t feel satiation, which is the other side of hunger. In late July I learned to swallow slurries again, which meant I could get some of the pleasure of taste, but everything I swallow has to be mixed with enough water for me to get the food down, and the water reduces calorie density. Sweet food, more than savory food, seems to activate the taste receptors that remain (in the back of my throat, esophagus and hard palate). In the war against the tumors that are extracting calories and nutrients from my fat and muscle and food, I have to inject calories and eat, but it’s an intellectual knowledge, like knowing I need to practice with spaced-repetition software to augment long-term memory, or someone who is wavering on their instrument needing to pick it up and play. The immediate animal sense of hunger is absent.

The food cravings that have characterized my life, and most people’s lives, don’t exist, or barely do; today, when they come on, I have to suppress them. I can’t eat pizza. Bess did pick up a pie from Doughbird and blended it, but the result didn’t satisfy. I can’t handle spicy, so the noodles, buns, and other food at nearby Din Tai Fung in San Diego are probably out. At Taste of the Himalayas, I’ll have to ask for the food not to be spicy. Anything that depends on texture doesn’t work that well. The VitaMix’s real utility is turning things like broccoli and cheddar into the same texture as pudding, once enough water is added to the blending container. Food blended into a slurry is far better than not being able to consume anything by mouth, but it lacks the satisfactions of normal eating. Food has become a major art form in the United States, perhaps taking the place of visual art (which descended into visual noise decades ago: industrial design has supplanted “visual art”) or music (which has become ubiquitous and caught in re-treats), and it was an art form I happily participated in. Now I’m excluded from it, permanently. Not having food cravings that can be satisfied sets me apart from the typical life experience, too. Most Americans are trying to keep their weight stable or lose weight; it’s the cancer patients like me who struggle in the opposite direction.

Most days I feel gnarly, which further discourages me from eating. I want the headaches and exhaustion to go away; the persistent, shooting pain that’s been brewing and expanding in my right ear distracts me even now, as I write this sentence.

I can’t lift weights much any more either. I used to go to the gym a couple times a week, alternating two major lifts with one or two minor lifts. It worked well enough, though I never got really good and have struggles with hamstring, hip, and lower back mobility—too much time sitting and not enough time stretching. Since May, I’ve spent more time in beds and sitting on couches than I ever have before. Keytruda seems to exhaust me. Life seems to exhaust me. Maybe it’s the tumors stealing all those calories that exhausts me. Whatever it is, the burning drive to lift weights has abated, along with the sense of my future.

I sit too much. A lot of what calories I get in me come via pump, and the pump takes half an hour to an hour to inject food. Sitting seems like the most natural position when this happens. But then I get the muscle, joint, and ligament problems that come from sitting. And my left quadricep hasn’t recovered from being raided for material to make the “flap” that takes the place of my tongue. I’ve tried to lightly jog to make a crosswalk light, and my left leg nearly buckles underneath me. I can’t pant properly through my mouth. Maybe this is a gym-related issue, but my mouth dries out almost instantly when I try to breathe through it. The bodily indignities add up.

The mucus in my throat has been bad enough to make me consider auto-termination. It makes eating worse, because food gets caught in the mucus, which chokes me, sometimes to the point where I actually can’t breathe for an alarming period of time, and then I have to hack the mucus up, and I can see the swallowed food caught in it. No matter how much water I drink, no matter how much I nebulize saline when it comes time to hack up the morning’s mucus, I can still see flecks of whatever I ate the night before in it.

There are a lot of moments in cancer treatment when you don’t know whether you’re experiencing victory or defeat. The weight issue is one of those: I celebrate when I see it peak above 140, and yet I can’t seem to get it sustainably, consistently above there. The tumor seems to increase metabolic demand and thus consume the calories that should be going to the rest of my body.

Despite all I’ve written above, in some ways I was well-prepared for the physical misery of cancer and cancer treatment. For the last 15 years, I’ve eaten minimal sugar or simple carbs like bread. In high school and college I ran; in the last decade, I’ve shifted to lifting weights, though poor mobility meant persistent struggles with the squat and deadlift, however—it turns out that some people, like me, can’t turn decades of time sitting or running into good squat mechanics without mobility training. When real physical adversity came, I could lose a lot of weight and still physically function. As hard as walking was that first month out of surgery, I was better prepared than most people for walking by the physical training preceding surgery. My struggle against my body is brutal, and yet likely easier than the average person’s because of the reserve I built before becoming ill.

I wish I could find some poetic, beautiful way to end this essay—an epiphany, a wrapping up, a hopeful note on the triumph of the human spirit over tumoric adversity. I can’t right now, though, maybe because I’m too tired, too wasted away, and too unlikely to ameliorate either condition before the end. The struggle will go on, but I’m pretty sure there’s no victory for me. At the end of The Lord of the Rings, Frodo is too damaged by the weapons and devices of the enemy to stay in and enjoy the Shire, which he spent six books and 500,000 words attempting to save. He takes ship from the Grey Havens to Valinor, where he can find peace. I don’t live in Middle-earth and for me there no Grey Havens, no ships, no Valinor, and, in all likelihood, no victory over this foe residing in my neck and lungs. That is my burden, and I try not to dwell on aspects of it that will not change, but I also acknowledge the unabating misery that wars with the love for and connection to other people, the things which keep me here even when I long for a peace that I darkly suspect will come only one way.

If you’ve gotten this far, consider the Go Fund Me that’s funding ongoing care.


* I’m now in a clinical trial that’s testing a bispecific antibody called “petosemtamab.” If you’d like to see a lot of preliminary data on petosemtamab, this presentation from April 2023 offers it: 29 out of 49 patients were still alive after 11.5 months, which is an amazing rate in recurrent / metastatic (R /M) HNSCC. The goal, I think, is to be able to offer petosemtamab, and/or Moderna’s mRNA-4157, before and after the first surgery—upon or close to initial patient presentation. That should reduce recurrence rates, and petosemtamab and mRNA-4157 don’t have the toxicity profile of chemotherapy or radiation, so they should be able to be given even to patients like me, who seemed to be at lower recurrence risk. It’s too late for me, but I hope there are many fewer “total glossectomies” in the future than there are now, thanks to early petosemtamab and/or Keytruda/pembrolizamab.

Clinical update about where the cancer is, and what’s happening with treatment:

A lot of doctors have been reading the squamous cell carcinoma saga, and they keep asking for clinical detail about what’s going on. Although they don’t literally say: “The emotional love story is great and all, but we really want to know about disease progression and the clinical plan,” I get that that’s what they’re yearning for deep in their souls. It doesn’t make them unromantic—if anything, their commitment to medicine is equivalent to that of a great love, outlasting most actual relationships (if the physician divorce rate is to be believed).

On Wednesday I started a clinical trial of petosemtamab (MCLA-158) at the University of California-San Diego Medical Center. Early data is promising: 31 out of 43 patients in a previous trial saw their tumors either shrink or stay the same size.* Relative to the recurrent / metastatic squamous cell carcinoma of the head and neck (R / M HNSCC) baseline, that’s really good! Relative to more successful cancer treatments, having only 16 out of 43 patients see their tumors shrink is—well, the math is what it is. Still, petosemtamab is a plausible path forward, and a plausible path forward didn’t exist until recently.

The article about early data says: “Of the patients who responded, the median [duration of response] DOR was 6.0 months.” If I—or, rather, my tumors—respond to petosemtamab, I can expect the treatment to keep the tumors in check for about six months. It’s possible to get lucky and have the petosemtamab affect the tumors longer, and it’s obviously also possible that petosemtamab will stop working before six months, if it works at all. From what I’ve gathered, the long-term plan for oncologists and patients is to combine petosemtamab with immunotherapies like pembrolizumab, and possibly with chemotherapies, to see if petosemtamab generates synergistic responses. I’m getting 1100mg of petosemtamab every two weeks; 1100mg and 1500mg doses are being tested.

Bess and I have also been thinking about what to do if two-month or three-month CT scans show petosemtamab failing to contain the tumors: Magrolimab is a possible answer. RAPA-201 at Hackensack University Medical Center is another. There are other clinical study drugs at UCSD that may be conceivable routes forward. A fecal transplant from a pembrolizumab responder combined with additional pembrolizumab is also possible: this sounds ridiculous but it’s a real line of research, especially in Europe. A casual search shows articles like “The potential of fecal microbiota transplantation in oncology” and “Efficacy of Responder-derived Fecal Microbiota Transplant (R-FMT) and Pembrolizumab in Anti-PD-1 Refractory Patients with Advanced Melanoma.” Most research appears to be in melanoma thus far, but not all of it. Changing the tumor microenvironment might lead to significantly improved responses to treatments, which means that the unreliable markers clinicians currently use to guide treatment might not matter as much as the cellular environment around the tumor.

A patient who isn’t responding to a life-saving treatment like pembrolizumab might become someone who does, just by having the poop from a responder put in their colon via colonoscopy. Sign me up! This potential door was opened by Bess and Dr. Jamie Bering, a Mayo gastroenterologist who is currently wading through tons of red tape to both get the approval to perform the treatment on me, and to find a responder to “donate.” Both these things require FDA and IRB approval—a glacially slow process—and, two months in, neither have given the thumbs up. Right now, my default path is dying within twelve months and more likely eight (in July, I didn’t know how fast the cancer was moving or whether chemo would temporarily halt it, and I consider all the time since the massive May surgery to be “bonus time”), so there’s no real downside to experimenting.

As far as I can tell, petosemtamab shows some similarities to another antibody called BCA101, since both drugs target EGFR mutations. BCA101 wasn’t available when Bess and I were working to find the right clinical trials, so the petosemtamab trial is where I’m at. Bess is working on a monster essay about the clinical trial process, which is full of detail about the insanity of the process from the patient’s perspective. Though it seems odd to me, petosemtamab is presently only available at UCSD in the United States, despite there being a bunch of trial sites in Europe. There’s presumably a behind-the-scenes reason.

I don’t think I’ve stated clearly and in order what happened, and how it happened:

* Late summer 2022: I notice a sensitive area in the back left side of my tongue. I suspect I bit the tongue by accident and that it’s slow to heal. But the area doesn’t heal, and I eventually see a community ear, nose and throat (ENT) doctor named Jacob Ossoff at Valley ENT in Scottsdale. He orders a biopsy. The first attempt at biopsy is unsuccessful due to the excruciating pain from essentially trying to cut out a piece of my tongue with minimal numbing medication. Bess canvasses doctors online, and apparently “not much numbing medication” is standard of care and many other doctors think ENTs are sadists. Around Sept. 26 we get the biopsy news: squamous cell carcinoma. Ossoff and his partner refer me to Michael Hinni at the Mayo Clinic, who specializes in surgeries that include a “flap”—that is, taking a piece of muscle from another part of the body and implanting it into the tongue.

* Oct. 20, 2022: Dr. Hinni cuts out the carcinoma using a Co2 laser (very futuristic) and gets clean margins. No flap is necessary. The carcinoma is 9mm deep and displays “perineural invasion,” which means that it’s invaded nerves in the tongue. These count as “high-risk features” that argue for radiation. Given what’s happened since, I wish we’d done chemo along with the radiation, but at the time I was pleased to avoid chemo. I get to leave the hospital the day after surgery. Physician notes observe: “T2N0M0 oral tongue SCC with PNI, LVSI, and aggressive pattern of invasion status post left partial glossectomy and left modified radical neck dissection receiving adjuvant RT.”

* Dec. 1, 2022 to Jan. 13, 2023: Intensity Modulated Radiation Therapy (IMRT); 30 fractions; 6,000 cGy.

* April 26, 2023: PET scan is hot, and we hope it’s osteomyelitis. A fine needle biopsy and a core biopsy are both inconclusive. A surgical biopsy on May 11 reveals a cancer recurrence. Throughout May, I get steadily more severe headaches and steadily greater fatigue.

* May 22, 2023: Start pembrolizumab.

* May 25, 2023: Total glossectomy; Dr. Hinni leads the surgery and his colleague, Tom Nagle, makes the flap from muscle in my leg. This surgery was supposed to be a hemiglossectomy—losing half the tongue—but the tumor had sprinted across my tongue and invaded both lingual arteries (the main blood vessels supplying the tongue), so my entire tongue had to be removed. So I woke up with the “flap” instead of a tongue. It’s better than dying, although I wasn’t so sure at the time. I understood going in that the surgery plan was a plan, not a guarantee.

*July 21, 2023: A CT scan shows a recurrence in the neck and metastases in the lungs. The CT was supposed to be checking on post -operative bone healing, to see whether I could do any jaw-stretching exercises after the surgery. Bess and I had spent a lot of time in June and July trying to decide whether we should add chemo on top of pembrolizumab; oddly, no one has rigorously tested whether chemo is helpful for people with R / M HNSCC who get salvage surgery with clean margins. We know that chemo kills some HNSCC cells, even if it does not remove gross tumors. So, in theory, chemo may remove errant cancer cells. But we don’t have firm evidence. Some oncologists said we should do pembrolizumab only; some said chemo is a 50-50 option, or a reasonable option, and we elected for it. Life moved faster than us, however.

* July 24, 2023: Pembrolizumab/chemo: Paxitaxel and Carbolatin.

* August 14, 2023: Another pembrolizumab/chemo round.

* Sept. 5: I’m scheduled for another round here, but instead we have a six-week washout period for the petosemtamab trial. So I skip the pembro and chemo. I do okay, physically, until around Sept. 15, when headaches begin to assault me again, and fatigue increases.

The petosemtamab exclusion criteria include: “Any systemic anticancer therapy within 4 weeks or 5 half-lives whichever is longer of the first dose of study treatment. For cytotoxic agents that have major delayed toxicity ( e.g. mitomycin C,nitrosoureas), or anticancer immunotherapies, a washout period of 6 weeks is required.” So I thought I’d only have a four-week washout period, since carboplatin and paclitaxel have relatively short half lives. I did fairly well for four weeks after pembro/chemo, and then the headaches started up.

* September 27: First dose of petosemtamab. Ongoing headaches make daily life a challenge. Petosemtamab doesn’t appear to generate any side effects, but by Oct. 3 I get a gnarly rash on my chest, back, and face, with extensive itching on the face.


* There’s a copy of the presentation itself here.

Strange trip: Psychedelics and confronting the fear of death

For many people, taking a psychedelic like psilocybin is one of the most revelatory, profound, bizarre, beautiful, notable experiences of their lives. I’m one. It’s hard to enumerate all the things psychedelics have done with me, to me, and for me, but, given that a metastasizing squamous cell carcinoma is likely to end me, reducing my fear of death is a big one—albeit not a virtue I imagined would be germane so early in my life. I thought I’d have many more bike rides, walks with my wife, Bess, cups of coffee, and books to read—but treatment-refractory cancer means that I’ve been hit with the existential slap sooner than most. In another essay I testified about the powerful effects psychedelics have had on me:

Part of being ready to die comes, I think, from psychedelics; I wrote in “How do we evaluate our lives, at the end? What counts, what matters?”: “Bess and psychedelics taught me to love, and the importance of love, and yet too soon now I must give everything back.” There’s a longer, yet-to-be-written essay about how psychedelics cause me to see myself as a tiny instantiation of the vast, interconnected human whole, which will comfortingly go on even when I flicker out.

Michael Pollan’s book How to Change Your Mind is great and also covers a lot of existential territory. I’m looking for a copy to quote from and can’t find it, because I’ve given so many copies away. Pollan describes the way psychedelics are being used palliatively for end-of-life care, which is, strangely where I now find myself. Fortunately, I have a Kindle copy, and now I can authoritatively say that Pollan writes about how “researchers [have] been giving large doses of psilocybin—the active ingredient in magic mushrooms—to terminal cancer patients as a way to help them deal with their ‘existential distress’ at the approach of death.” Moreover, for many people, “psychedelics [help] to escape the prison of self.” I guess I can say that psychedelics prophylactically assuaged my fear of death, the way Zofran might be taken to prevent nausea.

Even before the present circumstances, from psychedelics I learned how not just to know but to deeply feel and internalize that we’re all part of the show for such a short time, and then it’s someone else’s turn, and that is okay. Until science radically expands healthy lives—which will be great, but it’s not clear whether we’re near to or far from that series of breakthroughs—we’re not here for long, and then we yield up the gift, whether willing with grace or unwillingly with fear.

In How To Change Your Mind, Pollan writes that he “interviewed at length more than a dozen people who had gone on guided psychedelic journeys” and found that, like me:

For many of [the people he interviewed about their psychedelic experiences], these were among the two or three most profound experiences of their lives, in several cases changing them in positive and lasting ways. To become more “open”—especially at this age, when the grooves of mental habit have been etched so deep as to seem inescapable—was an appealing prospect. And then there was the possibility, however remote, of having some kind of spiritual epiphany. Many of the people I’d interviewed had started out stone-cold materialists and atheists, no more spiritually developed than I, and yet several had had “mystical experiences” that left them with the unshakable conviction that there was something more to this world than we know—a “beyond” of some kind that transcended the material universe I presume to constitute the whole shebang. I thought often about one of the cancer patients I interviewed, an avowed atheist who had nevertheless found herself “bathed in God’s love.”

During my first psychedelic journey, I epiphanically understood visual art for the first time. Time and space seemed malleable. I saw life as a series of information problems or logic gates, and the stripping away of life’s surface to see what’s underneath helped me not fear the unknown. Logically, I understand that there’s no reason one should cause the other—that stripping the surface should help me not fear the unknown, including death—and yet that is how things unfolded for me. Feelings became more real to me. Like many people, my ego dissolved and allowed me to merge with all of life. Dying ceased being scary.

I emerged from that psychedelic with a great appreciation for love, which, along with progress and continuous improvement, is one of the great binding forces of the universe. But love can’t be indiscriminate: any person should be judicious in who they bind to. So many people don’t seem open to love, or to understand that it is an action verb and a skill that should be cultivated, and so their capacity for love shrivels like an unwatered plant. Maybe they’re not being giving enough, but being too giving and accepting of others, which puts a person at risk of scammers, parasites, and similar problems. Too much defensiveness can be just as problematic as too little.

Although I’m not in my 50s (like most of the Pollan interviewees; I’m also extraordinarily unlikely to ever reach that age), psychedelics dramatically increased my self-perceived openness. I don’t wholly know what I think about life after death or what is beyond material experience, but, regardless of what there is or isn’t, psychedelics unlocked a sense of human and technological sublime—and that sense of the sublime lets me see my own smallness in the world, and yet I also have seen that my contributions to the world are unique (like everybody’s, but that’s okay). The sublime revealed itself using what was already in my mind. Psychedelics seems to access my subconscious too, in ways I don’t expect, and psychedelics helped me see myself as lucky in numerous ways—including lucky to have experienced the psychedelic mind state itself, before the end. That sense of gratitude sustains me now, through the horrors of treatment and the loss of the tongue.

I don’t know whether many of the feelings and senses of revelation that psychedelics facilitate are true. They may not be. It may also be that the “truth” or falseness of the psychedelic mindset is irrelevant, like asking if purple sounds good. Psychedelics seem to temporarily short-circuit the logical mind in order to let the imaginative / feeling mind wholly take over, which can, I’d guess, be scary for some people, at least if they’re not being guided effectively, or if they’re not in a safe “set and setting,” to use the preferred psychedelic lingo. I come out of the psychedelic head space and feel utterly different—but am I, or is the feeling a lie? Does the question matter, or do the answers?

It could be that the psychedelic reinforces what’s already there. For example, I was interested in stoic philosophy and life before I took psychedelics, and the taking of psychedelics may simply have reinforced some of the notions I’d already absorbed from books—being ready to die, if that is one’s fate, seems like a stoic stance (particularly given Seneca’s socially meaningful auto-termination). Perhaps the psychedelics only slightly ratcheted up the underlying tendency.

I’ve spent most of my life being a thinker more than a feeler, but taking psychedelics balanced me out. It let me do both, and to reconcile apparent opposites. When I was young I think I worked to repress my emotions as a survival mechanism in a milieu that, to put it lightly, didn’t reward emotional expression. That isn’t uncommon, I suspect, since many people who experiment with psychedelics or therapy (and ideally both: psychedelics and MDMA appear to be incredible, underutilized therapeutic tools) find themselves better able to be emotionally expressive and better able to accept the love and affection of others. A lot of us are emotionally shriveled, for reasons I don’t want to speculate on here (despite my penchant for dubious speculation), and treatments that can help that are scarce. Therapy and support groups work for some people, but both work better with psychedelics. Once psychedelics make it through the FDA gauntlet, thanks to the work of the Multidisciplinary Association for Psychedelic Studies (MAPS), we’ll look back on non-psychedelic therapy as not terribly effective—it’ll be like comparing shamanism to medicine. Shamanism may be an interesting topic of study, but if there’s actually something wrong with you, you want the medicine.

Bess eavesdropped on some of the above paragraphs and then came up to me and gave me a hug and a squeeze and said: “I don’t want to do the world without you. You stay.” She gave me a hard slap on the ass and told me it’s decided. I hope she’s right. I’m trying hard to stay, however much psychedelics have made me accept death, without being suicidal or wanting to court death. If I had the skillset to work on treatments to radically extend life, I’d work on them, and I encourage others who have those skillsets to keep working. It may be that understanding and defeating aging and cancer are ultimately the same thing. I don’t have the expertise to evaluate those claims, but they seem plausible from the outside.

I read an interview with the movie director Francis Ford Coppola where he says:

I have no fear of death whatsoever. I used to do a little experiment for the fun of it in my elevator here, when I go down to the first floor. I can control the elevator so when I go in, I shut out the lights and I’m in total darkness. I think, when I get to the first floor that I’m going to be dead. As I go down, I think, I had such an interesting life, I got to be a movie director, have a wife and children, had so much fun with them, got to be in the wine business, go through everything, and as I’m lost in all these interesting thoughts, the door opens on the first floor and I’m not dead. I walk out.

Psychedelics are for me like Coppola’s elevator. Many people take a psychedelic and have the experience of dying while in the psychedelic head space, where it doesn’t bother them. During the psychedelic experience, time also seems to halt, and one hour turns into years.

I’m deliberately not describing the content of psychedelic trips: that content usually seems banal to outside observers, and words are notoriously for capturing the feelings generated in the psychedelic state. Hearing about other people’s psychedelic experiences is like hearing about other people’s vacations—rarely satisfying. The people who can make their vacations vivid find work as travel writers. The shaping of experience through the craft of language is hard, and for psychedelics inadequate.

The last two times I’ve taken psychedelics, I’ve set the same intention before starting: to accept death. But the psychedelic experience is unpredictable; sometimes you get what you get, not what you think you need, and the result is strange and peculiar and worth doing. Both trips were generative and beautiful, though if I learned anything about accepting death, it’s that I’ve probably already done it. Life is a strange trip. The thing I can’t accept, and that will likely trouble me until the last moments, is that I don’t want to abandon Bess, and that I am worried she will be lonely, and no psychedelic can stop that fear and pain. Psychedelics may help many things but can’t help all things. Though I’ve been talking to all of our friends and family about supporting Bess after I pass, I know that she’ll be desperately lonely in a way no psychedelic can ameliorate, and I’ll be dead and so unable to do anything to alleviate the existential pain she’ll likely carry with her always.

If you’ve gotten this far, consider the Go Fund Me that’s funding ongoing care.


Here is Tyler Cowen on why he doesn’t personally use psychedelics. Those reasons seem fine for him but are probably not generally applicable. As Cowen says, there are also probably diminishing returns to psychedelics, which is consistent with most things human do.